Online inquiry

IVTScrip™ mRNA-Human ADAMTS17, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK7701MR)

This product GTTS-WK7701MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & N1-Methylpseudo-UTP. It ecodes the ADAMTS17 protein. This product can be used in Oogenesis phase fetal germ cell-related researches.
Specifications
Product type mRNA
Modified bases N1-Methylpseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_139057.4
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 170691
UniProt ID Q8TE56
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ADAMTS17, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) (GTTS-WK7701MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK27111MR IVTScrip™ mRNA-Human ARHGEF18, (Cap 1, Pseudo-UTP, 30 nt-poly(A)) mRNA ARHGEF18
GTTS-WK12540MR IVTScrip™ mRNA-Human ADGRF5, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ADGRF5
GTTS-WK19643MR IVTScrip™ mRNA-Human ALS2, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ALS2
GTTS-WK10738MR IVTScrip™ mRNA-Human ADGRE3, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ADGRE3
GTTS-WK10071MR IVTScrip™ mRNA-Human ACTR2, (Cap 0, 2-Thio-UTP, 30 nt-poly(A)) mRNA ACTR2
GTTS-WK9188MR IVTScrip™ mRNA-Human ADAM10, (Cap 0, Pseudo-UTP, 30 nt-poly(A)) mRNA ADAM10
GTTS-WK12159MR IVTScrip™ mRNA-Human ACTG1, (Cap 1, 5-Methyl-CTP, 120 nt-poly(A)) mRNA ACTG1
GTTS-WK15821MR IVTScrip™ mRNA-Human ANKRD36BP1, (Cap 0, 5-Methyl-CTP, 120 nt-poly(A)) mRNA ANKRD36BP1
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →